• 中文版
  • Home
  • About Us
    • Contract Research Organization
    • Contract Development and Manufacturing Organization
    • Accolades
    • Publications
  • Services Overview
  • Discovery Chemistry
    • Synthetic Chemistry
    • Medicinal Chemistry
    • Library Chemistry
    • Peptide Chemistry
    • Fragment Based Screening
    • Computer Aided Drug Design
    • Analytical Services
    • Protein Structure
  • Biology & Pharmacology
    • Oncology
    • Pathology Core Facility
    • Immunology
    • Tumor Immunology
    • Neuroscience
    • Cell Biology
    • In Vitro Biology
    • Metabolic & Cardiovascular Diseases
    • Epigenetics
  • Biologics Discovery
    • Antibody Discovery
    • Protein Science
    • Biologics Analytical Services
    • B Cell Cloning
  • DMPK / Exploratory Toxicology
    • DMPK / Exploratory Toxicology
    • Biomarkers, Preclinical & Clinical Sample Bioanalysis
    • Large molecule PK/BA services
  • Biologics CMC
    • Stable Cell Line Development
    • Process Development
    • Formulation Development
    • Aseptic Filling and Freeze-drying
    • Drug Developability / Manufacturability study
    • Final Container Extractables & Leachables Study
    • Analytical Development and Testing
    • GMP Production
  • Small Molecule CMC
    • Process R&D Services
    • Process Safety
    • Analytical Development
    • Pre-Formulation Development
    • Formulation Development
    • ICH Stability Studies
    • CMC CTD Support
    • Manufacturing
  • Blog
  • Careers
  • News & Events
  • Contact Us
  • Download Center

Call us today! +86 21 5132 0088

contact@chempartner.com
中文版
Shanghai ChemPartner Shanghai ChemPartner Shanghai ChemPartnerShanghai ChemPartner
  • Home
  • About Us
    • About ChemPartner
    • CRO
    • CDMO
    • Accolades
    • Publications
  • Services
    • Discovery Chemistry
      • Synthetic Chemistry
      • Medicinal Chemistry
      • Library Chemistry
      • Peptide Chemistry
      • Fragment Based Screening
      • Computer Aided Drug Design
      • Analytical Services
      • Protein Structure
    • Biology & Pharmacology
      • Oncology
      • Pathology Core Facility
      • Immunology
      • Tumor Immunology
      • Cell Biology
      • In Vitro Biology
      • Neuroscience
      • Metabolic & Cardiovascular Diseases
      • Epigenetics
    • Biologics Discovery
      • Antibody Discovery
      • Protein Science
      • Biologics Analytical Services
      • B Cell Cloning
    • DMPK / Exploratory Toxicology
      • DMPK / Exploratory Toxicology
      • Biomarkers, Preclinical & Clinical Sample Bioanalysis
      • Large molecule PK/BA services
    • Biologics CMC
      • Stable Cell Line Development
      • Process Development
      • Formulation Development
      • Aseptic Filling and Freeze-drying
      • Drug Developability / Manufacturability study
      • Final Container Extractables & Leachables Study
      • Analytical Development and Testing
      • GMP Production
    • Small Molecule CMC
      • Process R&D Services
      • Process Safety
      • Analytical Development
      • Pre-Formulation Development
      • Formulation Development
      • ICH Stability Studies
      • CMC CTD Support
      • Manufacturing
  • Blog
  • Careers
  • News & Events
  • Contact Us
  • Download Center
  • pic101
  • pic102

ChemPartner Exhibits at BIOtech Japan 2017

7月 6, 2017 | Press Release |

Shanghai, China (July 6th, 2017) – Shanghai ChemPartner recently exhibited at the 16th International Biotech & Life Sciences Exhibition & Conferences on June 28-30 at the Tokyo Big Sight in Japan. BIOtech Japan is Asia’s leading biotechnology and pharma R&D event specialized in biotech, drug discovery, pharmaceutical development, regenerative medicine, and personalized medicine.

This comprehensive event gathered 650 exhibitors, and nearly 2000 industry insiders, including conference delegates, keynote speakers, sponsors, and guests from Asia as well as other countries around the globe. BIOtech Japan provides interactive networking opportunities involving academics, biotech companies, and pharma companies. Participants benefit from 250 wide-ranging presentations delivering new technical data, case studies, innovation, and industry brilliant insights.

ChemPartner’s biology and DMPK teams attended the exhibition to introduce ChemParter’s services to attendees. The Biology department specializes in drug discovery services for several important therapeutic areas, such as oncology including tumor immunology, immunology/inflammation, neuroscience and metabolic disorders. ChemPartner prides itself on numerous validated key discovery assays and assay panels (e.g., largest cancer lines, epigenetics, histology/pathology) for different targets. Assays and panels are routinely used and customized, and in vivo models are performed in the AAALAC approved, state-of-the-art animal housing and breeding facility.

The Drug Metabolism Pharmacokinetic (DMPK) & Exploratory Toxicology department at ChemPartner consists of bioanalytical (regulated- and non-GLP), in vitro ADME, pharmacokinetics, and toxicology groups. The team works closely with internal medicinal chemistry, pharmacology, and biologics departments, providing support for drug discovery as well as translational medicine through expertise in formulation, in vitro-in vivo extrapolation, PK/PD modeling, biomarker analysis, and metabolomics.

The company looks forward to attending BIOtech 2018 to see the latest news and innovations in the industry!

FOR MORE INFORMATION

Livia Legg, MS, Chief Commercial Officer

news@chempartner.com

Tags: BIOtech
1
Share

Latest News

Shanghai ChemPartner was awarded “TOP 10 CMOs in 2019”

Shanghai ChemPartner was awarded “TOP 10 CMOs in 2019”

07/19/2019

Contract manufacturers play a significant role when it ...

Dr. Teddy Yang appointed to Vice President and Head of Biologics Discovery at Shanghai ChemPartner

03/29/2019

Shanghai, China(Mar 28, 2019) – Shanghai ChemPartner to...

ChemPartner Will Participate in BIO-Europe Spring in Vienna, Austria in March 2019

03/18/2019

Shanghai, China (March X, 2019) – March 25-27, 2019, Ch...

ChemPartner will be at the Boulder Peptide Symposium 2018

ChemPartner will be at the Boulder Peptide Symposium 2018

09/25/2018

ChemPartner, a leader in Peptide Synthesis and Developm...

Shanghai  ChemPartner  Announces Merger Deal Closure with Quantum

Shanghai ChemPartner Announces Merger Deal Closure with Quantum

08/16/2018

SHANGHAI, Aug. 16, 2018 /PRNewswire/ — Shanghai  ...

Berkeley Lights and ChemPartner Collaborate on Accelerating Antibody Discovery

06/28/2018

EMERYVILLE, Calif., June 27, 2018 /PRNewswire/ — Berkel...

Tag Cloud

2017 AACR Agreement Antibody Engineering art Berkeley Lights Best Life Science BIOtech Blend Boston Capital Market Chemistry ChemPartner Congratulates CPhI CPSA Shanghai 2016 CRO DMPK Exploratory Toxicology Labs layout Merger Deal PEGS PEGS CHINA Peptide Pharma Pharmacology product PTF Qidong Quantum Hi-Tech China Biological Research Facility San Diego San Francisco Shanghai Shanghai ChemPartner ShangPharma Sponsor Strategic Corporate Restructuring Tarveda Therapeutic Top 10 CMOs Vice President World ADC

Give us a Message

You can leave us a message by quick contact box and we'll get back to you, asap. Thanks!

Send Message

Logo

ChemPartner is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry.

Get started today.

Contact Us
  • ChemPartner Co., Ltd.
  • 1F & 3F, Block A, 2829 JinKe Road, Zhangjiang Hi-Tech Park, PuDong New Area, Shanghai China, 201203
  • +86 21 5132 0088
  • contact@chempartner.com

© 2019 — Shanghai ChemPartner Co., Ltd. All Rights Reserved  About Us  Careers  Contact Us  Privacy Policy  Sitemap

  • Home
  • Contact
  • Buy Highend
Prev Next